A U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss drug Zepbound in the U.S. The decision was filed late on Wednesday in response to a lawsuit brought by a compounding industry group that challenged the U.

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli Lilly has established an online portal to accept submissions for possible locations of future U.

With styles for the whole family, these pieces will bring your wardrobe out of hibernation.

The reductions come at a time of significant growth overall for Lilly. and soon after the announcement of plans to build new manufacturing facilities at four yet-to-be-named U.S. locations.

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out about its atopic dermatitis treatment Ebglyss.

Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 construction workers.

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self